BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35018302)

  • 1. Liver Transplantation for Hepatic Adenoma: A UNOS Database Analysis and Systematic Review of the Literature.
    Ziogas IA; Tasoudis PT; Serifis N; Alexopoulos SP; Montenovo MI; Shingina A
    Transplant Direct; 2022 Feb; 8(2):e1264. PubMed ID: 35018302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies.
    Tan DJH; Lim WH; Yong JN; Ng CH; Muthiah MD; Tan EX; Xiao J; Lim SY; Pin Tang AS; Pan XH; Kabir T; Bonney GK; Sundar R; Syn N; Kim BK; Dan YY; Noureddin M; Loomba R; Huang DQ
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1475-1484. PubMed ID: 35181565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnicity-Specific Differences in Liver Transplant Outcomes Among Adults With Primary Sclerosing Cholangitis: 2005-2017 United Network for Organ Sharing/Organ Procurement and Transplantation Network.
    Bayable A; Ohabughiro M; Cheung R; Wong RJ
    J Clin Exp Hepatol; 2021; 11(1):30-36. PubMed ID: 33679046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of transjugular intrahepatic porto-systemic shunt on post liver transplantation outcomes: Study based on the United Network for Organ Sharing database.
    Mumtaz K; Metwally S; Modi RM; Patel N; Tumin D; Michaels AJ; Hanje J; El-Hinnawi A; Hayes D; Black SM
    World J Hepatol; 2017 Jan; 9(2):99-105. PubMed ID: 28144391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Transplantation for Langerhans Cell Histiocytosis: A US Population-Based Analysis and Systematic Review of the Literature.
    Ziogas IA; Kakos CD; Wu WK; Montenovo MI; Matsuoka LK; Zarnegar-Lumley S; Alexopoulos SP
    Liver Transpl; 2021 Aug; 27(8):1181-1190. PubMed ID: 33484600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in infants listed for liver transplantation: A retrospective cohort study using the United Network for Organ Sharing database.
    Jimenez-Rivera C; Nightingale S; Benchimol EI; Mazariegos GV; Ng VL
    Pediatr Transplant; 2016 Nov; 20(7):904-911. PubMed ID: 27378124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time.
    Mehta N; Dodge JL; Grab JD; Yao FY
    Hepatology; 2020 Mar; 71(3):943-954. PubMed ID: 31344273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival.
    Sundaram V; Kogachi S; Wong RJ; Karvellas CJ; Fortune BE; Mahmud N; Levitsky J; Rahimi RS; Jalan R
    J Hepatol; 2020 Mar; 72(3):481-488. PubMed ID: 31669304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States.
    Young K; Liu B; Bhuket T; Gish RG; Wong RJ
    J Viral Hepat; 2019 Mar; 26(3):350-361. PubMed ID: 30412318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.
    Young K; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
    J Viral Hepat; 2017 Sep; 24(9):789-796. PubMed ID: 28273387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underestimation of Liver Transplantation for Alcoholic Hepatitis in the National Transplant Database.
    Lee BP; Im GY; Rice JP; Weinberg E; Hsu C; Fix OK; Therapondos G; Han H; Victor DW; Eswaran S; Maddur H; Terrault NA
    Liver Transpl; 2019 May; 25(5):706-711. PubMed ID: 30882995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
    Mehta N; Frenette C; Tabrizian P; Hoteit M; Guy J; Parikh N; Ghaziani TT; Dhanasekaran R; Dodge JL; Natarajan B; Holzner ML; Frankul L; Chan W; Fobar A; Florman S; Yao FY
    Gastroenterology; 2021 Nov; 161(5):1502-1512. PubMed ID: 34331914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.
    Santori G; Andorno E; Morelli N; Antonucci A; Bottino G; Mondello R; Castiglione AG; Valente R; Ravazzoni F; Di Domenico S; Valente U
    Transpl Int; 2005 Jan; 18(1):65-72. PubMed ID: 15612986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
    Mehta N; Dodge JL; Roberts JP; Yao FY
    J Hepatol; 2021 Apr; 74(4):829-837. PubMed ID: 33188904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplant center experience influences spontaneous survival and waitlist mortality in acute liver failure: An analysis of the UNOS database.
    Wong NZ; Schaubel DE; Reddy KR; Bittermann T
    Am J Transplant; 2021 Mar; 21(3):1092-1099. PubMed ID: 32741074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
    Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
    Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between liver resection and liver transplantation on outcomes in patients with solitary hepatocellular carcinoma meeting UNOS criteria: a population-based study of the SEER database.
    Yang A; Ju W; Yuan X; Han M; Wang X; Guo Z; Wei X; Wang D; Zhu X; Wu L; He X
    Oncotarget; 2017 Nov; 8(57):97428-97438. PubMed ID: 29228622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current State of Liver Transplantation for Colorectal Liver Metastases in the United States: A Call for Standardized Reporting.
    Sasaki K; Ruffolo LI; Kim MH; Fujiki M; Hashimoto K; Imaoka Y; Melcher ML; Aucejo FN; Tomiyama K; Hernandez-Alejandro R
    Ann Surg Oncol; 2023 May; 30(5):2769-2777. PubMed ID: 36719568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.